BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stadler R, Assaf C, Klemke CD, Nashan D, Weichenthal M, Dummer R, Sterry W. Short German guidelines: cutaneous lymphomas. J Dtsch Dermatol Ges. 2008;6 Suppl 1:S25-S31. [PMID: 18801140 DOI: 10.1111/j.1610-0387.2008.06710.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Knobler R, Valero T, Just U. Update zur Extrakorporalen Photopherese. hautnah 2021;20:207-212. [DOI: 10.1007/s12326-021-00467-1] [Reference Citation Analysis]
2 Garbe C, Schadendorf D, Tilgen W, Gutzmer R, Berking C, Mohr P, Kaufmann R, Breitbart E, Weber C, Volkenandt M, Hauschild A. 30 years German Dermatologic Cooperative Oncology Group (DeCOG). J Dtsch Dermatol Ges 2021;19:1682-97. [PMID: 34677891 DOI: 10.1111/ddg.14628] [Reference Citation Analysis]
3 Garbe C, Schadendorf D, Tilgen W, Gutzmer R, Berking C, Mohr P, Kaufmann R, Breitbart E, Weber C, Volkenandt M, Hauschild A. 30 Jahre Arbeitsgemeinschaft Dermatologische Onkologie (ADO). J Dtsch Dermatol Ges 2021;19:1682-97. [PMID: 34677896 DOI: 10.1111/ddg.14628_g] [Reference Citation Analysis]
4 Sarfraz H, Gentille C, Ensor J, Wang L, Wong S, Ketcham MS, Joshi J, Pingali SRK. Primary cutaneous anaplastic large-cell lymphoma: a review of the SEER database from 2005 to 2016. Clin Exp Dermatol 2021. [PMID: 34081802 DOI: 10.1111/ced.14777] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Kempf W, Stadler R. Maligne Lymphome der Haut. Braun-Falco’s Dermatologie, Venerologie und Allergologie 2018. [DOI: 10.1007/978-3-662-49544-5_109] [Reference Citation Analysis]
6 Kroeger K, Elsayad K, Moustakis C, Haverkamp U, Eich HT. Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities. Strahlenther Onkol 2017;193:1024-30. [PMID: 28785772 DOI: 10.1007/s00066-017-1188-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
7 Schiller M, Tsianakas A, Sterry W, Dummer R, Hinke A, Nashan D, Stadler R. Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol 2017;31:1841-7. [PMID: 28557110 DOI: 10.1111/jdv.14366] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
8 Kempf W, Stadler R. Maligne Lymphome der Haut. Braun-Falco's Dermatologie, Venerologie und Allergologie 2017. [DOI: 10.1007/978-3-662-49546-9_109-1] [Reference Citation Analysis]
9 Erkiert-Polguj A, Halbina A, Polak-Pacholczyk I, Rotsztejn H. Light-emitting diodes in photodynamic therapy in non-melanoma skin cancers--own observations and literature review. J Cosmet Laser Ther 2016;18:105-10. [PMID: 26735126 DOI: 10.3109/14764172.2015.1114635] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
10 Patir P, Vural F. Treatment of mycosis fungoides, in the era of stem cell transplantation. World J Dermatol 2016; 5(1): 52-56 [DOI: 10.5314/wjd.v5.i1.52] [Reference Citation Analysis]
11 Kempf W, Cerroni L. Kutane Lymphome und Leukämien. Histopathologie der Haut 2016. [DOI: 10.1007/978-3-662-45133-5_38] [Reference Citation Analysis]
12 Elsayad K, Kriz J, Moustakis C, Scobioala S, Reinartz G, Haverkamp U, Willich N, Weishaupt C, Stadler R, Sunderkötter C, Eich HT. Total Skin Electron Beam for Primary Cutaneous T-cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics 2015;93:1077-86. [DOI: 10.1016/j.ijrobp.2015.08.041] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
13 Just U, Knobler R. Update zur extrakorporalen Photopherese. Hautarzt 2015;66:804-9. [DOI: 10.1007/s00105-015-3702-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
14 Förster D, Assaf C. Primär kutane T-Zell-Lymphome in der Praxis. Im Focus Onkologie 2015;18:47-53. [DOI: 10.1007/s15015-015-1826-x] [Reference Citation Analysis]
15 Kempf W, Cerroni L. Kutane Lymphome und Leukämien. Histopathologie der Haut 2015. [DOI: 10.1007/978-3-662-44367-5_38-1] [Reference Citation Analysis]
16 Morales-Suárez-Varela MM, Olsen J, Villeneuve S, Johansen P, Kaerlev L, Llopis-González A, Wingren G, Hardell L, Ahrens W, Stang A, Merletti F, Gorini G, Aurrekoetxea JJ, Févotte J, Cyr D, Guénel P. Occupational exposure to chlorinated and petroleum solvents and mycosis fungoides. J Occup Environ Med 2013;55:924-31. [PMID: 23887697 DOI: 10.1097/JOM.0b013e3182941a1c] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
17 Wirtz M, Helbig D. [Granulomatous mycosis fungoides: combination therapy with bexarotene and PUVA]. Hautarzt 2014;65:274-6. [PMID: 24671704 DOI: 10.1007/s00105-014-2784-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Weißbach A, Herberhold S, Wenzel J, Löffler K. Lidschwellung unklarer Genese. Ophthalmologe 2014;111:65-68. [DOI: 10.1007/s00347-013-2925-8] [Reference Citation Analysis]
19 Schlaak M, Pickenhain J, Theurich S, Skoetz N, von Bergwelt-Baildon M, Kurschat P. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. Cochrane Database Syst Rev 2013;:CD008908. [PMID: 23986525 DOI: 10.1002/14651858.CD008908.pub3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
20 Assaf C, Becker JC, Beyer M, Cozzio A, Dippel E, Klemke C, Kurschat P, Weichenthal M, Stadler R. Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin - Consensus of the lymphoma group of the Working Group Dermatologic Oncology: Consensus liposomal doxorubicin for CTCL. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2013;11:338-47. [DOI: 10.1111/ddg.12012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Schlaak M, Theurich S, Pickenhain J, Skoetz N, Kurschat P, von Bergwelt-baildon M. Allogeneic stem cell transplantation for advanced primary cutaneous T-cell lymphoma: A systematic review. Critical Reviews in Oncology/Hematology 2013;85:21-31. [DOI: 10.1016/j.critrevonc.2012.06.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
22 Wollina U. Cutaneous T cell lymphoma: update on treatment: Cutaneous T cell lymphoma: treatment update. International Journal of Dermatology 2012;51:1019-36. [DOI: 10.1111/j.1365-4632.2011.05337.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
23 Rabenhorst A, Schlaak M, Heukamp LC, Förster A, Theurich S, von Bergwelt-Baildon M, Büttner R, Kurschat P, Mauch C, Roers A, Hartmann K. Mast cells play a protumorigenic role in primary cutaneous lymphoma. Blood 2012;120:2042-54. [PMID: 22837530 DOI: 10.1182/blood-2012-03-415638] [Cited by in Crossref: 94] [Cited by in F6Publishing: 100] [Article Influence: 8.5] [Reference Citation Analysis]
24 Terhorst D, Mestel D, Humme D, Sterry W, Beyer M. Evaluation of different methods in the follow-up of patients with indolent types of primary cutaneous lymphomas: Follow-up examinations in patients with indolent primary cutaneous lymphomas. British Journal of Dermatology 2012;166:1295-300. [DOI: 10.1111/j.1365-2133.2012.10896.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
25 Humme D, Möbs M, Pullmann S, Haidar A, Beyer M, Sterry W, Assaf C. Maligne Lymphome der Haut: Update zu Diagnostik und Therapie kutaner T-Zell-Lymphome. Hautarzt 2012;63:423-36. [DOI: 10.1007/s00105-012-2387-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
26 Booken N, Goerdt S, Klemke C. Clinical spectrum of primary cutaneous CD30-positive anaplastic large cell lymphoma: an analysis of the Mannheim Cutaneous Lymphoma Registry: Clinical spectrum cutaneous anaplastic large T-cell-lymphoma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2012;10:331-9. [DOI: 10.1111/j.1610-0387.2011.07794.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
27 Schlaak M, Pickenhain J, Theurich S, Skoetz N, von Bergwelt-Baildon M, Kurschat P. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. Cochrane Database Syst Rev. 2012;1:CD008908. [PMID: 22258991 DOI: 10.1002/14651858.cd008908.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
28 Kempf W, Stadler R. Lymphome. Braun-Falco’s Dermatologie, Venerologie und Allergologie 2012. [DOI: 10.1007/978-3-642-24163-5_109] [Reference Citation Analysis]
29 Kempf W, Denisjuk N, Kerl K, Cozzio A, Sander C. Primary cutaneous B-cell lymphomas: CME Article. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2012;10:12-23. [DOI: 10.1111/j.1610-0387.2011.07852.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
30 Gholam P, Weberschock T, Denk K, Enk A. Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis. Dermatology 2011;222:358-62. [PMID: 21757880 DOI: 10.1159/000329025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
31 Günther C, Zimmermann N, Berndt N, Grosser M, Stein A, Koch A, Meurer M. Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma. Am J Pathol 2011;179:1434-42. [PMID: 21741937 DOI: 10.1016/j.ajpath.2011.05.040] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
32 Klemke C. Systemische Therapie kutaner Lymphome. Hautarzt 2011;62:436-43. [DOI: 10.1007/s00105-010-2043-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
33 Hüsken A, Tsianakas A, Hensen P, Nashan D, Loquai C, Beissert S, Luger T, Sunderkötter C, Schiller M. Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma: PEG-IFN α-2b plus PUVA in CTCL. Journal of the European Academy of Dermatology and Venereology 2012;26:71-8. [DOI: 10.1111/j.1468-3083.2011.04011.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
34 Felcht M, Booken N, Stroebel P, Goerdt S, Klemke CD. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry. J Am Acad Dermatol 2011;64:135-43, 143.e1-4. [PMID: 21167409 DOI: 10.1016/j.jaad.2009.12.062] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
35 Babilas P, Szeimies R. Photodynamic Therapy. Laser and IPL Technology in Dermatology and Aesthetic Medicine 2011. [DOI: 10.1007/978-3-642-03438-1_28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 Schlaak M, Theurich S, Skoetz N, Pickenhain J, Engert A, Kurschat P, Bergwelt-baildon M. Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T cell lymphoma. Cochrane Database of Systematic Reviews 2010. [DOI: 10.1002/14651858.cd008908] [Reference Citation Analysis]
37 Schmitz S. Von der Wichtigkeit wissenschaftsgetriebener Studien. Best Practice Onkologie 2010;5:1-1. [DOI: 10.1007/s11654-010-0251-z] [Reference Citation Analysis]
38 Booken N, Weiss C, Utikal J, Felcht M, Goerdt S, Klemke CD. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome. J Dtsch Dermatol Ges 2010;8:428-38. [PMID: 20180887 DOI: 10.1111/j.1610-0387.2010.07319.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
39 Sebastian Mestel D, Beyer M, Möbs M, Steinhoff M, Sterry W, Assaf C. Zanolimumab, a human monoclonal antibody targeting CD4 in the treatment of mycosis fungoides and Sézary syndrome. Expert Opinion on Biological Therapy 2008;8:1929-39. [DOI: 10.1517/14712590802528696] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]